Listing #6304071 novocure.com
280
Novocure (NASDAQ: NVCR) is an oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields.
Category
Website Performance
| firstMeaningfulPaint | 1.25 Sec |
| observedLastVisualChange | 1.66 Sec |
| observedFirstVisualChange | 1.22 Sec |
| observedNavigationStartTs | 604760834141 |
| maxPotentialFID | 0.05 Sec |
| observedLargestContentfulPaint | 1.3 Sec |
| observedFirstMeaningfulPaint | 1.3 Sec |
| observedFirstVisualChangeTs | 604762058141 |
| observedNavigationStart | 0 Sec |
| cumulativeLayoutShiftMainFrame | 0 Sec |
| totalCumulativeLayoutShift | 0 Sec |
| observedFirstContentfulPaint | 1.3 Sec |
| firstContentfulPaint | 0.98 Sec |
| observedLargestContentfulPaintTs | 604762132193 |
| largestContentfulPaint | 1.67 Sec |
| observedFirstContentfulPaintTs | 604762132193 |
| observedFirstPaintTs | 604761732634 |
| observedFirstMeaningfulPaintTs | 604762132193 |
| observedDomContentLoadedTs | 604761863304 |
| totalBlockingTime | 0 Sec |
| observedTotalCumulativeLayoutShift | 0 Sec |
| observedLargestContentfulPaintAllFramesTs | 604762132193 |
| interactive | 1.25 Sec |
| observedLargestContentfulPaintAllFrames | 1.3 Sec |
| cumulativeLayoutShift | 0 Sec |
| observedCumulativeLayoutShiftMainFrame | 0 Sec |
| observedSpeedIndexTs | 604762129214 |
| observedSpeedIndex | 1.3 Sec |
| observedCumulativeLayoutShift | 0 Sec |
| observedFirstContentfulPaintAllFrames | 1.3 Sec |
| observedLoad | 1.3 Sec |
| observedTraceEnd | 3.62 Sec |
| observedLoadTs | 604762133523 |
| observedTraceEndTs | 604764455521 |
| observedFirstPaint | 0.9 Sec |
| observedTimeOriginTs | 604760834141 |
| speedIndex | 1.52 Sec |
| observedLastVisualChangeTs | 604762491141 |
| observedFirstContentfulPaintAllFramesTs | 604762132193 |
| observedTimeOrigin | 0 Sec |
| observedDomContentLoaded | 1.03 Sec |
